查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2019264

全球术前皮肤准备市场：依最终用户、产品类型、剂型、应用领域、通路及地区进行分析－市场规模、产业趋势、机会分析及2026-2035年预测

Global Preoperative Skin Preparation Market: Analysis End User, By Product Type, Formulation Type, Application Area, Distribution Channel, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球术前皮肤消毒市场正快速扩张，反映出全球外科医学界对感染预防和病人安全的日益重视。预计到2025年，该市场规模将达到13.102亿美元，到2035年将达到21.665亿美元。这一成长意味着在2026年至2035年的预测期内，复合年增长率约为5.16%。这种稳定上升的趋势凸显了对先进皮肤消毒产品和给药系统投资的不断增加，这些产品和系统对于降低手术部位感染（SSI）的发生率至关重要，而手术部位感染是所有医疗机构面临的重大挑战。

推动市场成长的主要因素之一是新兴国家术前皮肤清洁方案的快速普及。在亚太地区、拉丁美洲和非洲部分地区，随着医疗基础设施的改善和手术量的增加，对有效感染控制产品的需求激增。在这些市场，人们越来越意识到手术部位感染（SSI）的临床和经济影响，促使医院和手术中心优先考虑可靠的皮肤清洁通讯协定。

显着的市场趋势

术前皮肤消毒剂市场高度一体化，呈现寡占格局，由少数几家实力雄厚的「一级」公司主导，这些公司占据了大部分市场份额并製定了行业标准。在这些领导企业中，贝克顿·迪金森公司（BD）凭藉其广受认可的ChloraPrep™产品系列，成为无可争议的施用器之王。 BD的竞争优势在于其创新且取得专利的施用器设计，该设计可有效防止液体滞留，这对于确保消毒剂的持续安全涂抹至关重要。

同时，3M的医疗保健业务（现已分拆为Solventum公司营运）凭藉其DuraPrep™和SoluPrep™产品线继续发挥重要的市场影响力。儘管组织架构有所调整，但这些品牌在术前皮肤消毒领域依然是强大的竞争对手。 Solventum的优点在于其在聚合物化学领域的专业知识，这使得该公司能够开发出可在皮肤上形成持久薄膜并有效杀死微生物的消毒剂。

Ecolab 和 Medline Industries 在大宗解决方案领域和医院合约方面占据主导地位，业务规模和分销能力是决定性因素。特别是 Medline，它利用其广泛的分销网络，将皮肤消毒剂与定製手术托盘捆绑销售，从而在门诊手术中心 (ASC) 领域占据主导地位。

主要成长要素

手术部位感染 (SSI) 的高发生率是推动术前皮肤清洁市场强劲成长的关键因素。 SSI 的发生率极高，约占全球医疗相关感染 (HAI) 的 20%。如此高的发生率不仅严重威胁病患安全，还会显着增加病患的发生率、延长住院时间并提高再入院率。 SSI 的广泛影响凸显了采取有效预防措施的迫切性，也使得先进的皮肤清洁技术成为医疗机构感染控制策略的核心。

新机会的趋势

随着术前皮肤清洁市场向2035年发展，最有价值创造前景的机会正涌现于材料科学与人工智慧（AI）的交叉领域。这种融合将彻底革新皮肤消毒方式，超越传统的化学配方，并融入智慧技术，进而提升精准度、功效和病人安全性。将旨在提供卓越抗菌性能的先进材料与优化应用和监测的AI驱动系统相结合，预示着一个新时代的到来——一个真正意义上的「智慧」皮肤清洁时代。

优化障碍

氯己定（CHG）因其广谱抗菌特性和已被证实能有效降低手术部位感染率，长期以来一直是术前皮肤清洁消毒剂的黄金标准。其在全球医院和手术中心的广泛应用，反映了其强大的疗效和良好的安全性。然而，近期趋势表明，氯己定使用量的增加与严重I型超敏反应（包括危及生命的过敏性休克）的发生率上升之间存在令人担忧的关联。虽然这些过敏反应相对罕见，但它们对病人安全构成重大风险，并正引起临床医生和监管机构的日益关注。

目录

第一章执行摘要：全球术前皮肤科治疗市场

第二章：调查方法与研究框架

  • 研究目标
  • 产品概述
  • 市场区隔
  • 定性研究
    • 一手和二手资讯
  • 量化研究
    • 一手和二手资讯
  • 按地区分類的主要调查受访者组成
  • 本研究的前提
  • 市场规模估算
  • 数据检验

第三章：全球术前皮肤准备市场概览

  • 产业价值链分析
    • 原料和活性成分的采购
    • 配方和生产
    • 经销和供应链管理
    • 终端用户消费和临床应用
  • 产业展望
    • 10种常见皮肤病及治疗方法[PY1.1]
  • PESTLE分析
  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争强度
  • 市场成长及前景
    • 市场收入估算与预测（2020-2035 年）
    • 按产品类型分類的价格趋势分析

第四章：全球术前皮肤准备市场分析

  • 竞争格局概述
    • 市场集中度
    • 企业市场占有率分析（以金额为准，%），2025 年
    • 竞争对手分析与基准测试

第五章：全球术前皮肤准备市场分析

  • 市场动态和趋势
    • 成长要素
    • 抑制因子
    • 机会
    • 主要趋势
  • 市场规模及预测（2020-2035）
    • 依产品类型
      • 关键见解
        • 氯己定类产品
        • 优碘溶液
        • 酒精製剂
        • 消毒擦拭巾
        • 其他术前皮肤准备产品
    • 製剂形式
      • 关键见解
        • 水溶液
        • 形式
        • 凝胶
        • 喷
        • 预浸湿擦拭巾
    • 按应用程式字段
      • 关键见解
        • 一般外科
        • 整形外科手术
        • 心血管外科
        • 整形手术
        • 其他外科手术
    • 最终用户
      • 关键见解
        • 医院
        • 门诊手术中心
        • 专科诊所
        • 家庭医疗保健服务提供者
        • 研究机构
    • 透过分销管道
      • 关键见解
        • 直销
        • 药局
        • 线上零售
        • 医疗用品商店
        • 销售代理
    • 按地区
      • 关键见解
        • 北美洲
          • 我们
          • 加拿大
          • 墨西哥
        • 欧洲
          • 西欧
            • 英国
            • 德国
            • 法国
            • 义大利
            • 西班牙
            • 其他西欧国家
          • 东欧
            • 波兰
            • 俄罗斯
            • 其他东欧国家
        • 亚太地区
          • 中国
          • 印度
          • 日本
          • 韩国
          • 澳洲和纽西兰
          • ASEAN
              • 印尼
              • 马来西亚
              • 泰国
              • 新加坡
              • 其他东协国家
          • 其他亚太地区
        • 中东和非洲
          • 阿拉伯聯合大公国
          • 沙乌地阿拉伯
          • 南非
          • 其他中东和非洲
        • 南美洲
          • 阿根廷
          • 巴西
          • 南美洲其他地区

第六章：北美市场分析

第七章：欧洲市场分析

第八章：亚太市场分析

第九章：中东和非洲市场分析

第十章：南美市场分析

第十一章：公司简介

  • 3M
  • B. Braun Melsungen
  • Baxter International
  • Betadine（Johnson &Johnson）
  • DuPont
  • Ecolab
  • Essity
  • GAMA Healthcare
  • Hibiclens（Molnlycke Health Care）
  • Kimberly-Clark
  • Medline Industries
  • Precept Medical Products
  • Smith &Nephew
  • SurgiCare
  • Theradome

第十二章附录

简介目录
Product Code: AA03261723

The global preoperative skin preparation market is experiencing rapid expansion, reflecting the growing emphasis on infection prevention and patient safety in surgical care worldwide. Valued at USD 1,310.2 million in 2025, the market is projected to reach an impressive USD 2,166.5 million by 2035. This growth represents a compound annual growth rate (CAGR) of approximately 5.16% during the forecast period from 2026 to 2035. The steady upward trajectory highlights increasing investments in advanced skin antiseptic products and delivery systems that are critical to reducing the incidence of surgical site infections (SSIs), which remain a major challenge across healthcare settings.

A key driver behind this market growth is the accelerated adoption of preoperative skin preparation solutions in emerging economies. As healthcare infrastructure improves and surgical volumes rise in regions such as Asia-Pacific, Latin America, and parts of Africa, there is a corresponding surge in demand for effective infection control products. These markets are witnessing increased awareness about the clinical and economic consequences of SSIs, prompting hospitals and surgical centers to prioritize reliable skin preparation protocols.

Noteworthy Market Developments

The market for preoperative skin preparation is highly consolidated, operating as an oligopoly dominated by a handful of powerful "Tier 1" companies that control the majority of market share and set industry standards. Among these leaders, Becton, Dickinson and Company (BD) stands out as the undisputed king of the applicator segment, primarily through its widely recognized ChloraPrep(TM) product portfolio. BD's competitive moat is built on innovative patented applicator designs that effectively prevent fluid pooling, which is crucial for ensuring consistent and safe application of antiseptics.

In parallel, 3M's healthcare business, now operating under the spin-off company Solventum, continues to exert significant influence with its DuraPrep(TM) and SoluPrep(TM) product lines. Despite the organizational changes, these brands remain formidable competitors within the preoperative skin preparation landscape. Solventum's strength lies in its expertise in polymer chemistry, which enables the creation of antiseptic solutions that form a durable microbial-locking film on the skin.

Ecolab and Medline Industries occupy a dominant position in the bulk solution segment and hospital contracting space, where the scale of operations and distribution capabilities are decisive factors. Medline, in particular, leverages its expansive distribution network to bundle skin preparation solutions with custom surgical trays, making it a dominant force in the ambulatory surgical center (ASC) tier.

Core Growth Drivers

The epidemic of surgical site infections (SSIs) stands as a critical driver behind the robust growth of the preoperative skin preparation market. SSIs are alarmingly prevalent, accounting for nearly 20% of all healthcare-associated infections (HAIs) worldwide. This high incidence not only poses a significant threat to patient safety but also contributes extensively to increased morbidity, prolonged hospital stays, and elevated readmission rates. The widespread impact of SSIs underscores the urgent need for effective preventive measures, positioning advanced skin preparation technologies at the forefront of infection control strategies within healthcare settings.

Emerging Opportunity Trends

As the preoperative skin preparation market advances toward 2035, the most exciting opportunities for value creation are emerging at the crossroads of material science and artificial intelligence (AI). This convergence is set to revolutionize the way skin antisepsis is approached, moving beyond traditional chemical formulations to incorporate intelligent technologies that enhance precision, efficacy, and patient safety. The integration of advanced materials engineered for superior antimicrobial performance with AI-driven systems capable of optimizing application and monitoring marks the dawn of a new era-one that can be aptly described as the era of "Smart" Skin Preparation.

Barriers to Optimization

Chlorhexidine (CHG) has long been regarded as the gold standard in antiseptic formulations for preoperative skin preparation due to its broad-spectrum antimicrobial properties and proven effectiveness in reducing surgical site infections. Its widespread adoption across hospitals and surgical centers worldwide reflects its strong efficacy and established safety profile. However, recent trends have highlighted a concerning correlation between the rising usage of chlorhexidine and an increase in severe Type I hypersensitivity reactions, including life-threatening anaphylaxis. These allergic reactions, although relatively rare, pose significant risks to patient safety and have drawn heightened attention from both clinicians and regulatory authorities.

Detailed Market Segmentation

By formulation, pre-filled applicators have become a dominant force in the preoperative skin preparation market, now capturing over 50% of the market's total value. This significant market share reflects a growing preference among healthcare providers for these ready-to-use delivery systems, which offer a combination of convenience, precision, and safety that traditional formulations cannot easily match. Pre-filled applicators eliminate the need for manual mixing or measurement of antiseptic solutions, reducing the risk of contamination and dosing errors, which is critical in maintaining stringent infection control standards in surgical environments.

By End Users, the landscape of surgical care has undergone a significant transformation, with traditional acute-care hospitals no longer serving as the sole epicenter of surgical volume. This shift is largely driven by remarkable advances in minimally invasive surgery (MIS) and robotic-assisted techniques, which have expanded the scope and complexity of procedures that can be safely and effectively performed outside conventional hospital settings. These technological innovations have made it possible to conduct sophisticated surgeries with smaller incisions, reduced trauma, and faster recovery times, creating new opportunities for alternative care environments.

By application, the preoperative skin preparation market is often superficially viewed as a single, uniform category. However, a deeper examination reveals that the specific surgical indication plays a critical role in determining the chemical formulations used, leaving no room for error due to the high stakes involved in infection prevention. Each type of surgery demands tailored skin preparations that effectively target the unique microbial risks associated with the procedure, ensuring optimal patient safety and clinical outcomes. This nuanced approach underscores the complexity of the market and highlights why different surgical segments exhibit varied demand patterns.

Segment Breakdown

By Product Type

  • Chlorhexidine-based Products
  • Povidone-iodine Solutions
  • Alcohol-based Preparations
  • Antiseptic Wipes
  • Other Skin Preparation Products

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Home Healthcare Providers
  • Research Laboratories

By Application Area

  • General Surgery
  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Cosmetic Surgery
  • Other Surgical Procedures

By Formulation Type

  • Aqueous Solutions
  • Foams
  • Gels
  • Sprays
  • Pre-soaked Wipes

By Distribution Channel

  • Direct Sales
  • Pharmacies
  • Online Retail
  • Medical Supply Stores
  • Distributors

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • In 2026, North America continues to serve as the cornerstone of the global textile winding machine market, capturing over 40% of total global revenues. This dominant market position reflects the region's advanced manufacturing capabilities, strong industrial infrastructure, and a robust demand for high-quality textile machinery across various sectors. The United States, as the largest economy within North America, plays a particularly pivotal role due to its sizeable textile production and strict regulatory landscape, which together create a lucrative but challenging environment for market participants.
  • A major factor driving the attractiveness and complexity of the US market is its uniquely punitive regulatory and reimbursement framework, particularly in the healthcare segment, where subsea well access systems and related technologies are also critical. The Centers for Medicare & Medicaid Services (CMS) has adopted stringent policies that classify many surgical site infections (SSIs) as "Never Events" or Hospital-Acquired Conditions (HACs). This classification has profound implications for hospitals and healthcare providers, as it directly affects reimbursement practices. Specifically, if a patient develops an SSI following surgery, CMS refuses to cover the costs associated with corrective treatments.

Leading Market Participants

  • 3M
  • B. Braun Melsungen
  • Baxter International
  • Betadine (Johnson & Johnson)
  • DuPont
  • Ecolab
  • Essity
  • GAMA Healthcare
  • Hibiclens (Molnlycke Health Care)
  • Kimberly-Clark
  • Medline Industries
  • Precept Medical Products
  • Smith & Nephew
  • SurgiCare
  • Theradome
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Preoperative Skin Preparation Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Preoperative Skin Preparation Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material & Active Ingredient Sourcing
    • 3.1.2. Formulation & Manufacturing
    • 3.1.3. Distribution & Supply Chain Management
    • 3.1.4. End-User Consumption & Clinical Application
  • 3.2. Industry Outlook
    • 3.2.1. Ten Common Skin Conditions with Treatment Options[PY1.1]
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Product Type

Chapter 4. Global Preoperative Skin Preparation Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Preoperative Skin Preparation Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Chlorhexidine-based Products
        • 5.2.1.1.2. Povidone-iodine Solutions
        • 5.2.1.1.3. Alcohol-based Preparations
        • 5.2.1.1.4. Antiseptic Wipes
        • 5.2.1.1.5. Other Skin Preparation Products
    • 5.2.2. By Formulation
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Aqueous Solutions
        • 5.2.2.1.2. Foams
        • 5.2.2.1.3. Gels
        • 5.2.2.1.4. Sprays
        • 5.2.2.1.5. Pre-soaked Wipes
    • 5.2.3. By Application Area
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. General Surgery
        • 5.2.3.1.2. Orthopedic Surgery
        • 5.2.3.1.3. Cardiovascular Surgery
        • 5.2.3.1.4. Cosmetic Surgery
        • 5.2.3.1.5. Other Surgical Procedures
    • 5.2.4. By End User
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Hospitals
        • 5.2.4.1.2. Ambulatory Surgical Centers
        • 5.2.4.1.3. Specialized Clinics
        • 5.2.4.1.4. Home Healthcare Providers
        • 5.2.4.1.5. Research Laboratories
    • 5.2.5. By Distribution Channel
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Direct Sales
        • 5.2.5.1.2. Pharmacies
        • 5.2.5.1.3. Online Retail
        • 5.2.5.1.4. Medical Supply Stores
        • 5.2.5.1.5. Distributors
    • 5.2.6. By Region
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. North America
          • 5.2.6.1.1.1. The U.S.
          • 5.2.6.1.1.2. Canada
          • 5.2.6.1.1.3. Mexico
        • 5.2.6.1.2. Europe
          • 5.2.6.1.2.1. Western Europe
            • 5.2.6.1.2.1.1. The UK
            • 5.2.6.1.2.1.2. Germany
            • 5.2.6.1.2.1.3. France
            • 5.2.6.1.2.1.4. Italy
            • 5.2.6.1.2.1.5. Spain
            • 5.2.6.1.2.1.6. Rest of Western Europe
          • 5.2.6.1.2.2. Eastern Europe
            • 5.2.6.1.2.2.1. Poland
            • 5.2.6.1.2.2.2. Russia
            • 5.2.6.1.2.2.3. Rest of Eastern Europe
        • 5.2.6.1.3. Asia Pacific
          • 5.2.6.1.3.1. China
          • 5.2.6.1.3.2. India
          • 5.2.6.1.3.3. Japan
          • 5.2.6.1.3.4. South Korea
          • 5.2.6.1.3.5. Australia & New Zealand
          • 5.2.6.1.3.6. ASEAN
              • 5.2.6.1.3.6.1.1. Indonesia
              • 5.2.6.1.3.6.1.2. Malaysia
              • 5.2.6.1.3.6.1.3. Thailand
              • 5.2.6.1.3.6.1.4. Singapore
              • 5.2.6.1.3.6.1.5. Rest of ASEAN
          • 5.2.6.1.3.7. Rest of Asia Pacific
        • 5.2.6.1.4. Middle East & Africa
          • 5.2.6.1.4.1. UAE
          • 5.2.6.1.4.2. Saudi Arabia
          • 5.2.6.1.4.3. South Africa
          • 5.2.6.1.4.4. Rest of MEA
        • 5.2.6.1.5. South America
          • 5.2.6.1.5.1. Argentina
          • 5.2.6.1.5.2. Brazil
          • 5.2.6.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Product Type
      • 6.2.1.2. By Formulation
      • 6.2.1.3. By Application Area
      • 6.2.1.4. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Product Type
      • 7.2.1.2. By Formulation
      • 7.2.1.3. By Application Area
      • 7.2.1.4. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Product Type
      • 8.2.1.2. By Formulation
      • 8.2.1.3. By Application Area
      • 8.2.1.4. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Product Type
      • 9.2.1.2. By Formulation
      • 9.2.1.3. By Application Area
      • 9.2.1.4. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Product Type
      • 10.2.1.2. By Formulation
      • 10.2.1.3. By Application Area
      • 10.2.1.4. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. 3M
  • 11.2. B. Braun Melsungen
  • 11.3. Baxter International
  • 11.4. Betadine (Johnson & Johnson)
  • 11.5. DuPont
  • 11.6. Ecolab
  • 11.7. Essity
  • 11.8. GAMA Healthcare
  • 11.9. Hibiclens (Molnlycke Health Care)
  • 11.10. Kimberly-Clark
  • 11.11. Medline Industries
  • 11.12. Precept Medical Products
  • 11.13. Smith & Nephew
  • 11.14. SurgiCare
  • 11.15. Theradome

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators